Skip to main content

Table 1 Characteristics of the study sample at baseline and 13 years follow-up

From: Long-term effects of intensive multifactorial treatment on aortic stiffness and central hemodynamics after 13 years with screen-detected type 2 diabetes: the ADDITION-Denmark trial

 

At baseline

At 13 years follow-up

Routine

Intensive

N

Routine

Intensive

N

n

169

242

 

169

242

 

Female sex

59 (34.9)

84 (34.7)

411

59 (34.9)

84 (34.7)

411

Age at inclusion (years)

58 (6.8)

58 (6.5)

411

58 (6.8)

58 (6.5)

411

Age at follow-up (years)

   

71 (6.72)

70 (6.63)

411

Follow-up time (years)

   

12.6 (1.41)

12.5 (1.42)

411

BMI (kg/m2)

31 (4.9)

30 (5.3)

399

30 (5.2)

30 (5.8)

410

Waist (cm)

104.7 (12.2)

104 (12.8)

399

105 (13.2)

106 (14.2)

407

Systolic blood pressure (mmHg)

148.3 (19.3)

145.6 (16.8)

399

141.2 (16.3)

137.4 (15.5)

410

Diastolic blood pressure (mmHg)

88.1 (10.6)

87.6 (9.6)

399

83.6 (9.9)

82.0 (9.3)

410

HbA1c (%)

6.7 (1.4)

6.9 (1.6)

395

6.7 (0.9)

6.9 (0.9)

410

HbA1c (mmol/mol)

50 (15)

52 (17)

395

50 (10)

52 (10)

410

Total cholesterol (mmol/L)

5.8 (1.2)

5.7 (1.1)

384

4.4 (1.0)

4.3 (1.0)

410

Triglycerides (mmol/L)

1.97 (1.3)

1.95 (1.3)

377

1.69 (0.7)

1.82 (0.9)

410

HDL cholesterol (mmol/L)

1.39 (0.3)

1.38 (0.4)

374

1.38 (0.4)

1.37 (0.4)

410

LDL cholesterol (mmol/L)

3.45 (1.0)

3.45 (1.0)

362

2.26 (0.8)

2.16 (0.8)

398

Albumine Creatinine ratio (mg/g)

2.95 (10.5)

1.88 (4.2)

372

8.31 (37.1)

5.89 (20.3)

406

Any glucose-lowering drug

s

411

106 (72.6)

149 (77.6)

338

 Metformin

411

91 (62.3)

131 (68.2)

338

 Insulin

411

24 (16.4)

36 (18.8)

338

 Sulphonylurea

411

10 (6.8)

16 (8.3)

338

Antihypertensives

62 (36.7)

79 (32.6)

411

120 (82.2)

165 (85.9)

338

 ACE/ARB blockers

25 (14.8)

37 (15.3)

411

101 (69.2)

147 (76.6)

338

 Betablockers

24 (14.2)

32 (13.2)

411

39 (26.7)

50 (26.0)

338

 Calcium antagonists

17 (10.1)

21 (8.7)

411

57 (39.0)

69 (35.9)

338

 Diuretics

35 (20.7)

41 (16.9)

411

66 (45.2)

105 (54.7)

338

Statins

21 (12.4)

35 (14.5)

411

113 (77.4)

155 (80.7)

338

Aspirin

15 (8.9)

24 (9.9)

411

66 (45.2)

119 (62.0)

338

Smoking

  

407

  

379

 Non-smoker

56 (33.7)

101 (41.9)

 

54 (34.2)

90 (40.7)

 

 Former smoker

63 (38.0)

81 (33.6)

 

79 (50.0)

104 (47.1)

 

 Current smoker

47 (28.3)

59 (24.5)

 

25 (15.8)

27 (12.2)

 

Alcohol use *

47 (29.2)

66 (29.9)

382

7.7 (8.9)

7.7 (9.0)

308

  1. Categorical data are expressed as n (%), and continuous data as means (SD)
  2. * Weekly alcohol consumption exceeding recommended intake (> 7 units in women and > 14 units in men)